Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis.

@article{Baker2014EffectsOS,
  title={Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis.},
  author={William L Baker and Lindsay R Smyth and Daniel M. Riche and Emily M Bourret and Kevin W. Chamberlin and William B White},
  journal={Journal of the American Society of Hypertension : JASH},
  year={2014},
  volume={8 4},
  pages={262-75.e9}
}
Sodium-glucose co-transporter 2 (SGLT2) inhibitors represent a new class of antihyperglycemic agents that block renal sodium and glucose reabsorption and may reduce blood pressure (BP). We assessed the BP lowering ability of these agents using meta-analytic techniques. PubMed, SCOPUS, and Cochrane Central were searched through October 2013. We included fully published randomized controlled trials (RCTs) that evaluated SGLT2 inhibitors in patients with type-2 diabetes mellitus and reported… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 95 extracted citations

Similar Papers

Loading similar papers…